Shenglan Tang, co-director of the Global Health Research Center at Duke Kunshan University, has co-authored a new commentary in the Lancet with Michael Merson calling for more far-reaching reform of the World Health Organization.
The commentary, “Transforming WHO: incremental reform is no longer sufficient,” was published April 10.

Beginning on November 10, 2025, China officially included the domestic-made bivalent human papillomavirus (HPV) vaccine into the National Immunization Program (NIP), providing two doses free of charge to girls aged 13 years. This measure marks a critical step in China’s participation in the global effort to eliminate cervical cancer and is also regarded as an important exploration in expanding immunization services from a focus on infants and young children toward a life-course approach. Consequently, the implementation of HPV vaccination under the NIP also carries an important mission: to lay the foundation for establishing the adolescent routine immunization service system.

As East and Southeast Asia ages rapidly, a new study involving researchers from Duke Kunshan University, Duke University and Duke-NUS Medical School maps the region’s long-term aging research landscape and identifies gaps in the data

A new collaborative study published in PLOS Global Public Health has revealed stark socioeconomic and geographic inequities in the availability of essential vaccines across China. Led by first author Mr. Lei Guo, Senior Research Fellow at the Innovation Lab for Vaccine Delivery Research at Duke Kunshan University, the project represents a major joint effort alongside the China National Health Development Research Center (NHDRC), Fudan University, the World Bank Group, Duke University, and Duke-NUS Medical School.